{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:16:47Z","timestamp":1784557007912,"version":"3.55.0"},"reference-count":32,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,27]]},"abstract":"<jats:p>The main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D) from the CONCEPTT study including subanalyses. Literature search was accessed through MEDLINE (1966\u2013September 2023) using the key terms: CONCEPTT, pregnancy, women, T1D, and CGM with limitations set to distinguish human subjects written in English. A total of 17 publications including one main clinical trial and 15 subanalyses have been published to date regarding the use of CGM in pregnant women with T1D which were conducted by a research group identified as the CONCEPTT Collaborative Group. While advances in maternal care have resulted in safer pregnancy for both the mother and child, women with preexisting T1D and pregnancy still experience higher rates of complications both in the short and long term. The use of CGM in pregnancy has not been studied extensively until more recently. The CONCEPTT clinical trial was a landmark study that involved several subanalyses. The main trial proved that CGM use in T1D pregnancy resulted in less hyperglycemia in the third trimester, reduced large for gestational age (LGA, &gt;90th percentile), reduced neonatal intensive care unit admissions lasting longer than 24 h, and reduced neonatal hypoglycemia. Although subanalyses showed a variety of results including \u2018inconclusive\u2019 due to lack of prespecification, it is believed that CGM in T1D during pregnancy is to be recommended and used for overall improved outcomes.<\/jats:p>","DOI":"10.1530\/ec-23-0407","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T09:59:25Z","timestamp":1701079165000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring"],"prefix":"10.1530","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0861-7139","authenticated-orcid":true,"given":"David Q","family":"Pham","sequence":"first","affiliation":[{"name":"Western University of Health Sciences, College of Pharmacy, Pomona, California, USA"},{"name":"Mary & Dick Allen Diabetes Center at Hoag Hospital, Newport Beach, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Thorsell","sequence":"additional","affiliation":[{"name":"Sansum Diabetes Research Institute, Santa Barbara, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Castorino","sequence":"additional","affiliation":[{"name":"Sansum Diabetes Research Institute, Santa Barbara, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Cobb","sequence":"additional","affiliation":[{"name":"Sansum Diabetes Research Institute, Santa Barbara, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Annals of Clinical Biochemistry","first-page":"37","article-title":"Monitoring motherhood: monitoring and optimizing glycaemia in women with pre-existing diabetes in pregnancy","volume":"59","author":"Meek","year":"2022","unstructured":"Meek CL. Monitoring motherhood: monitoring and optimizing glycaemia in women with pre-existing diabetes in pregnancy. Annals of Clinical Biochemistry20225937\u201345. (https:\/\/doi.org\/10.1177\/00045632211035815)"},{"key":"bib2","series-title":"Current Diabetes Reports","first-page":"4","article-title":"Emerging technologies for the management of T1D in pregnancy","volume":"18","author":"Yamamoto","year":"2018","unstructured":"Yamamoto JM & Murphy HR. Emerging technologies for the management of T1D in pregnancy. Current Diabetes Reports2018184. (https:\/\/doi.org\/10.1007\/s11892-018-0973-9)"},{"issue":"Supplement1","key":"bib3","series-title":"Diabetes Technology and Therapeutics","first-page":"S8","article-title":"Benefits of real-time continuous glucose monitoring in pregnancy","volume":"23","author":"Yamamoto","year":"2021","unstructured":"Yamamoto JM & Murphy HR. Benefits of real-time continuous glucose monitoring in pregnancy. Diabetes Technology and Therapeutics202123(Supplement1) S8\u2013S14. (https:\/\/doi.org\/10.1089\/dia.2020.0667)"},{"key":"bib4","series-title":"Diabetes Care","first-page":"1563","article-title":"Intensive glycemic treatment during T1D pregnancy: a story of (mostly) sweet success!","volume":"41","author":"Murphy","year":"2018","unstructured":"Murphy HR. Intensive glycemic treatment during T1D pregnancy: a story of (mostly) sweet success!Diabetes Care2018411563\u20131571. (https:\/\/doi.org\/10.2337\/dci18-0001)"},{"key":"bib5","series-title":"Lancet","first-page":"2347","article-title":"Continuous glucose monitoring in pregnant women with T1D (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","unstructured":"Feig DSDonovan LECorcoy RMurphy KEAmiel SAHunt KFAsztalos EBarrett JFRSanchez JJLeiva A, et al.Continuous glucose monitoring in pregnant women with T1D (CONCEPTT): a multicentre international randomised controlled trial. Lancet20173902347\u20132359. (https:\/\/doi.org\/10.1016\/S0140-6736(1732400-5)"},{"key":"bib6","series-title":"Annals of Translational Medicine","first-page":"188","article-title":"Does continuous glucose monitoring during pregnancy improve glycaemic and health outcomes in women with T1D?-what the CONCEPTT trial adds","volume":"6","author":"Farrar","year":"2018","unstructured":"Farrar D & Campbell MD. Does continuous glucose monitoring during pregnancy improve glycaemic and health outcomes in women with T1D?-what the CONCEPTT trial adds. Annals of Translational Medicine20186188. (https:\/\/doi.org\/10.21037\/atm.2018.03.08)"},{"key":"bib7","series-title":"Diabetes Care","first-page":"1593","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","unstructured":"Battelino TDanne TBergenstal RMAmiel SABeck RBiester TBosi EBuckingham BACefalu WTClose KL, et al.Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care2019421593\u20131603. (https:\/\/doi.org\/10.2337\/dci19-0028)"},{"key":"bib8","series-title":"ADA Clinical Compendia","first-page":"8","article-title":"Continuous glucose monitoring systems: categories and features","volume":"2018","author":"Chamberlain","year":"2018","unstructured":"Chamberlain JJ. Continuous glucose monitoring systems: categories and features. ADA Clinical Compendia201820188\u201310. (https:\/\/doi.org\/10.2337\/db20181-8)"},{"key":"bib9","series-title":"Journal of Diabetes Science and Technology","first-page":"1021","article-title":"The accuracy and efficacy of the dexcom G4 platinum continuous glucose monitoring system","volume":"9","author":"Nakamura","year":"2015","unstructured":"Nakamura K & Balo A. The accuracy and efficacy of the dexcom G4 platinum continuous glucose monitoring system. Journal of Diabetes Science and Technology201591021\u20131026. (https:\/\/doi.org\/10.1177\/1932296815577812)"},{"key":"bib10","series-title":"BMC Pregnancy and Childbirth","first-page":"1","article-title":"CONCEPTT: continuous glucose monitoring in women with T1D in pregnancy trial: a multi-center, multi-national, randomized controlled trial-study protocol","volume":"167","author":"Feig","year":"2016","unstructured":"Feig DSAsztalos ECorcoy RLeiva ADDonovan LHod MJavanovic LKeely EKollman CMcManus R, et al.CONCEPTT: continuous glucose monitoring in women with T1D in pregnancy trial: a multi-center, multi-national, randomized controlled trial-study protocol. BMC Pregnancy and Childbirth20161671\u20138."},{"key":"bib11","series-title":"Diabetes Care","first-page":"2471","article-title":"Pumps or multiple daily injections in pregnancy involving T1D: a prespecified analysis of the CONCEPTT randomized trial","volume":"41","author":"Feig","year":"2018","unstructured":"Feig DSCorcoy RDonovan LEMurphy KEBarrett JFRSanchez JJWysocki TRuedy KKollman CTomlinson G, et al.Pumps or multiple daily injections in pregnancy involving T1D: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care2018412471\u20132479. (https:\/\/doi.org\/10.2337\/dc18-1437)"},{"key":"bib12","series-title":"Diabetic Medicine","first-page":"1046","article-title":"Maternal glycaemic control and risk of neonatal hypoglycaemia in T1D pregnancy: a secondary analysis of the CONCEPTT trial","volume":"36","author":"Yamamoto","year":"2019","unstructured":"Yamamoto JMCorcoy RDonovan LEStewart ZATomlinson GBeardsall KFeig DSMurphy HR & CONCEPTT Collaborative Group. Maternal glycaemic control and risk of neonatal hypoglycaemia in T1D pregnancy: a secondary analysis of the CONCEPTT trial. Diabetic Medicine2019361046\u20131053."},{"key":"bib13","series-title":"Diabetic Medicine","first-page":"1652","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with T1D","volume":"36","author":"Murphy","year":"2019","unstructured":"Murphy HRFeig DSSanchez JJde Portu SSale A & CONCEPTT Collaborative Group. Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with T1D. Diabetic Medicine2019361652\u20131658. (https:\/\/doi.org\/10.1111\/dme.14046)"},{"key":"bib14","series-title":"Diabetic Medicine","first-page":"1841","article-title":"Dietary intakes of women with T1D before and during pregnancy: a pre-specified secondary subgroup analysis among CONCEPTT participants","volume":"37","author":"Neoh","year":"2020","unstructured":"Neoh SLGrisoni JAFeig DSMurphy HR & CONCEPTT Collaborative Group. Dietary intakes of women with T1D before and during pregnancy: a pre-specified secondary subgroup analysis among CONCEPTT participants. Diabetic Medicine2020371841\u20131848. (https:\/\/doi.org\/10.1111\/dme.13937)"},{"key":"bib15","series-title":"Diabetes Care","first-page":"e5","article-title":"Dietary patterns of insulin pump and multiple daily injection users during type 1 diabetes pregnancy","volume":"43","author":"Neoh","year":"2020","unstructured":"Neoh SLYamamoto JMFeig DSMurphy HR & CONCEPTT Collaborative Group. Dietary patterns of insulin pump and multiple daily injection users during type 1 diabetes pregnancy. Diabetes Care202043e5\u2013e7. (https:\/\/doi.org\/10.2337\/dc19-1908)"},{"key":"bib16","series-title":"Diabetes Care","first-page":"1178","article-title":"Continuous glucose monitoring in pregnancy: importance of analyzing temporal profiles to understand clinical outcomes","volume":"43","author":"Scott","year":"2020","unstructured":"Scott EMFeig DSMurphy HRLaw GR & CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnancy: importance of analyzing temporal profiles to understand clinical outcomes. Diabetes Care2020431178\u20131184. (https:\/\/doi.org\/10.2337\/dc19-2527)"},{"key":"bib17","series-title":"Diabetes Care","first-page":"681","article-title":"Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes","volume":"44","author":"Meek","year":"2021","unstructured":"Meek CLTundidor DFeig DSYamamoto JMScott EMMa DDHalperin JAMurphy HRCorcoy R & CONCEPTT Collaborative Group. Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes. Diabetes Care202144681\u2013689. (https:\/\/doi.org\/10.2337\/dc20-2360)"},{"key":"bib18","series-title":"BMC Pregnancy and Childbirth","first-page":"96","article-title":"Which growth standards should be used to identify large- and small-for-gestational age infants of mothers with type 1 diabetes? A pre-specified analysis of the CONCEPTT trial","volume":"21","author":"Meek","year":"2021","unstructured":"Meek CLCorcoy RAsztalos EKusinski LCLopez EFeig DSMurphy HR & CONCEPTTCollaborative Group. Which growth standards should be used to identify large- and small-for-gestational age infants of mothers with type 1 diabetes? A pre-specified analysis of the CONCEPTT trial. BMC Pregnancy and Childbirth20212196. (https:\/\/doi.org\/10.1186\/s12884-021-03554-6)"},{"key":"bib19","series-title":"Diabetologia","first-page":"1527","article-title":"Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?","volume":"64","author":"Bacon","year":"2021","unstructured":"Bacon SBurger DTailor MSanchez JJTomlinson GMurphy HRFeig DS & CONCEPTT Collaborative Group. Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?Diabetologia2021641527\u20131537. (https:\/\/doi.org\/10.1007\/s00125-021-05438-y)"},{"key":"bib20","series-title":"Diabetes Technology and Therapeutics","first-page":"710","article-title":"Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes","volume":"23","author":"Tundidor","year":"2021","unstructured":"Tundidor DMeek CLYamamoto JMartinez-Bru CGich IFeig DSMurphy HRCorcoy R & CONCEPTT Collaborative Group. Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes. Diabetes Technology and Therapeutics202123710\u2013714. (https:\/\/doi.org\/10.1089\/dia.2021.0073)"},{"key":"bib21","series-title":"CMAJ Open","first-page":"E627","article-title":"The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes iin 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial","volume":"9","author":"Ahmed","year":"2021","unstructured":"Ahmed RJGafni AHutton EKHu ZJSanchez JJMurphy HRFeig DS & CONCEPTT Collaborative Group. The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes iin 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial. CMAJ Open20219E627\u2013E634. (https:\/\/doi.org\/10.9778\/cmajo.20200128)"},{"key":"bib22","series-title":"Diabetes Care","first-page":"1826","article-title":"Reappearance of C-Peptide during the third trimester of pregnancy in type 1 diabetes: pancreatic regeneration or fetal hyperinsulinism?","volume":"44","author":"Meek","year":"2021","unstructured":"Meek CLOram RAMcDonald TJFeig DSHattersley ATMurphy HR & CONCEPTT Collaborative Group. Reappearance of C-Peptide during the third trimester of pregnancy in type 1 diabetes: pancreatic regeneration or fetal hyperinsulinism?Diabetes Care2021441826\u20131834. (https:\/\/doi.org\/10.2337\/dc21-0028)"},{"key":"bib23","series-title":"Biomarker Research","first-page":"67","article-title":"Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial","volume":"9","author":"Abolbaghaei","year":"2021","unstructured":"Abolbaghaei ALanglois MAMurphy HRFeig DSBurger D & CONCEPTT Collaborative Group. Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial. Biomarker Research2021967. (https:\/\/doi.org\/10.1186\/s40364-021-00322-8)"},{"key":"bib24","series-title":"Diabetic Medicine","first-page":"e14789","article-title":"Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: hypoglycaemia fear, glycaemic and pregnancy outcomes","volume":"39","author":"Bahrami","year":"2022","unstructured":"Bahrami JTomlinson GMurphy HRFeig DS & CONCEPTT Collaborative Group. Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: hypoglycaemia fear, glycaemic and pregnancy outcomes. Diabetic Medicine202239e14789. (https:\/\/doi.org\/10.1111\/dme.14789)"},{"key":"bib25","series-title":"Diabetologia","first-page":"2101","article-title":"Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes","volume":"66","author":"Meek","year":"2023","unstructured":"Meek CLStewart ZAFeig DSFurse SNeoh SLKoulman AMurphy HR & CONCEPTT Collaborative Group. Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes. Diabetologia2023662101\u20132116. (https:\/\/doi.org\/10.1007\/s00125-023-05989-2)"},{"key":"bib26","series-title":"European Endocrinology","first-page":"70","article-title":"Advances in type 1 diabetes technology over the last decade","volume":"15","author":"Zimmerman","year":"2019","unstructured":"Zimmerman CAlbanese-O'Neill A & Haller MJ. Advances in type 1 diabetes technology over the last decade. European Endocrinology20191570\u201376. (https:\/\/doi.org\/10.17925\/EE.2019.15.2.70)"},{"key":"bib27","series-title":"Diabetes Care","first-page":"2471","article-title":"Comment on Feig, et al. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial","volume":"42","author":"Sacha","year":"2018","unstructured":"Sacha JM & Lane WS. Comment on Feig, et al. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care2018422471\u20132479."},{"key":"bib28","article-title":"NICE. Diabetes in pregnancy: management from preconception to the postnatal period.","year":"2015","unstructured":"NICE. Diabetes in pregnancy: management from preconception to the postnatal period. NICE Guideline [NG3]. London, UK: NICE, 2015. (available at: https:\/\/www.nice.org.uk\/guidance\/ng3)"},{"key":"bib29","series-title":"Diabetes Care","first-page":"S254","article-title":"Management of diabetes in pregnancy: Standards of care in diabetes\u20142023","volume":"46","author":"Nuha","year":"2023","unstructured":"Nuha ASayed EAleppo GAroda VRBannuru RRBrown FMBruemmer DCollins BSHilliard MEIsaacs D, et al.Management of diabetes in pregnancy: Standards of care in diabetes\u20142023. Diabetes Care202346S254\u2013S266. (https:\/\/doi.org\/10.2337\/dc23-S015)"},{"key":"bib30","series-title":"Diabetes Care","first-page":"1826","article-title":"Comment on Meek, et al. Reappearance of C-Peptide during the third trimester of pregnancy in type 1 diabetes: Pancreatic regeneration or fetal hyperinsulinism?","volume":"45","author":"Ivanisevic","year":"2021","unstructured":"Ivanisevic M & Djelmis J. Comment on Meek, et al. Reappearance of C-Peptide during the third trimester of pregnancy in type 1 diabetes: Pancreatic regeneration or fetal hyperinsulinism?Diabetes Care2021451826\u20131834."},{"key":"bib31","series-title":"Diabetes Care","first-page":"1826","article-title":"Response to Comment on Meek, et al. Reappearance of C-Peptide during the third trimester in type 1 diabetes pregnancy: Pancreatic regeneration or fetal hyperinsulinism?","volume":"45","author":"Meek","year":"2021","unstructured":"Meek CLOram RAMcDonald TJFeig DSHattersley AT & Murphy HR. Response to Comment on Meek, et al. Reappearance of C-Peptide during the third trimester in type 1 diabetes pregnancy: Pancreatic regeneration or fetal hyperinsulinism?Diabetes Care2021451826\u20131834."},{"key":"bib32","series-title":"Diabetologia","first-page":"1143","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.","volume":"62","year":"2019","unstructured":"Kristensen K\u00d6gge LESengpiel VKj\u00f6lhede KDotevall AElfvin AKnop FKWiberg NKatsarou AShaat Net al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.Diabetologia2019621143\u20131153. (https:\/\/doi.org\/10.1007\/s00125-019-4850-0)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/13\/2\/EC-23-0407.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/2\/EC-23-0407.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/2\/EC-23-0407.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:57Z","timestamp":1784555217000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":32,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/ec-23-0407","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}